Annual Long Term Debt
$724.70 M
-$85.60 M-10.56%
December 31, 2023
Summary
- As of February 12, 2025, VRTX annual long term debt is $724.70 million, with the most recent change of -$85.60 million (-10.56%) on December 31, 2023.
- During the last 3 years, VRTX annual long term debt has fallen by -$164.80 million (-18.53%).
- VRTX annual long term debt is now -18.53% below its all-time high of $889.50 million, reached on December 31, 2020.
Performance
VRTX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$1.70 B
+$769.50 M+82.44%
September 30, 2024
Summary
- As of February 12, 2025, VRTX quarterly long term debt is $1.70 billion, with the most recent change of +$769.50 million (+82.44%) on September 30, 2024.
- Over the past year, VRTX quarterly long term debt has increased by +$981.60 million (+136.09%).
- VRTX quarterly long term debt is now at all-time high.
Performance
VRTX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
VRTX Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.6% | +136.1% |
| 3 y3 years | -18.5% | +136.1% |
| 5 y5 years | +24.6% | +173.4% |
VRTX Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.3% | at low | at high | +136.1% |
| 5 y | 5-year | -18.5% | +16.4% | at high | +226.2% |
| alltime | all time | -18.5% | >+9999.0% | at high | >+9999.0% |
Vertex Pharmaceuticals Incorporated Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.70 B(+82.4%) |
| Jun 2024 | - | $933.40 M(+29.4%) |
| Mar 2024 | - | $721.30 M(-0.5%) |
| Dec 2023 | $724.70 M(-10.6%) | $724.70 M(-2.7%) |
| Sep 2023 | - | $744.70 M(-3.0%) |
| Jun 2023 | - | $767.60 M(-2.7%) |
| Mar 2023 | - | $789.20 M(-2.6%) |
| Dec 2022 | $810.30 M(-8.7%) | $810.30 M(-1.7%) |
| Sep 2022 | - | $824.60 M(-2.7%) |
| Jun 2022 | - | $847.30 M(-2.9%) |
| Mar 2022 | - | $872.50 M(-1.7%) |
| Dec 2021 | $887.20 M(-0.3%) | $887.20 M(+1.2%) |
| Sep 2021 | - | $876.80 M(-1.9%) |
| Jun 2021 | - | $893.85 M(-0.6%) |
| Mar 2021 | - | $898.80 M(+1.0%) |
| Dec 2020 | $889.50 M(+42.8%) | $889.50 M(+62.8%) |
| Sep 2020 | - | $546.51 M(+4.7%) |
| Jun 2020 | - | $522.07 M(-2.0%) |
| Mar 2020 | - | $532.95 M(-14.4%) |
| Dec 2019 | $622.87 M(+7.1%) | $622.87 M(+3.0%) |
| Sep 2019 | - | $604.54 M(-1.2%) |
| Jun 2019 | - | $611.96 M(-1.9%) |
| Mar 2019 | - | $623.87 M(+7.3%) |
| Dec 2018 | $581.55 M(-0.4%) | $581.55 M(+0.9%) |
| Sep 2018 | - | $576.53 M(-0.2%) |
| Jun 2018 | - | $577.67 M(-0.1%) |
| Mar 2018 | - | $578.21 M(-1.0%) |
| Dec 2017 | $583.90 M(+12.0%) | $583.90 M(+2.9%) |
| Sep 2017 | - | $567.31 M(+3.1%) |
| Jun 2017 | - | $550.37 M(+4.0%) |
| Mar 2017 | - | $529.13 M(+1.5%) |
| Dec 2016 | $521.34 M(-29.5%) | $521.34 M(+3.3%) |
| Sep 2016 | - | $504.79 M(-13.2%) |
| Jun 2016 | - | $581.61 M(-12.0%) |
| Mar 2016 | - | $660.95 M(-10.6%) |
| Dec 2015 | $739.40 M(-6.8%) | $739.40 M(-8.4%) |
| Sep 2015 | - | $806.83 M(+5.1%) |
| Jun 2015 | - | $767.67 M(-2.3%) |
| Mar 2015 | - | $785.71 M(-0.9%) |
| Dec 2014 | $792.93 M(+61.9%) | $792.93 M(-2.1%) |
| Sep 2014 | - | $810.11 M(+56.3%) |
| Jun 2014 | - | $518.32 M(-0.9%) |
| Mar 2014 | - | $522.86 M(+6.8%) |
| Dec 2013 | $489.69 M(-28.3%) | $489.69 M(+13.4%) |
| Sep 2013 | - | $431.95 M(+11.6%) |
| Jun 2013 | - | $387.19 M(-47.1%) |
| Mar 2013 | - | $731.58 M(+7.1%) |
| Dec 2012 | $683.20 M(+49.8%) | $683.20 M(+70.8%) |
| Sep 2012 | - | $400.00 M(0.0%) |
| Jun 2012 | - | $400.00 M(0.0%) |
| Mar 2012 | - | $400.00 M(-12.3%) |
| Dec 2011 | $455.95 M(+14.0%) | $455.95 M(+14.0%) |
| Sep 2011 | - | $400.00 M(0.0%) |
| Jun 2011 | - | $400.00 M(0.0%) |
| Mar 2011 | - | $400.00 M(0.0%) |
| Dec 2010 | $400.00 M(+228.5%) | $400.00 M(-17.9%) |
| Sep 2010 | - | $487.23 M(+463.9%) |
| Jun 2010 | - | $86.41 M(-31.0%) |
| Mar 2010 | - | $125.32 M(+2.9%) |
| Dec 2009 | $121.77 M(-57.6%) | $121.77 M(-53.7%) |
| Sep 2009 | - | $262.84 M(+82.5%) |
| Jun 2009 | - | $144.00 M(-49.9%) |
| Mar 2009 | - | $287.50 M(0.0%) |
| Dec 2008 | $287.50 M | $287.50 M(0.0%) |
| Sep 2008 | - | $287.50 M(0.0%) |
| Jun 2008 | - | $287.50 M(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $287.50 M(+1337.7%) |
| Mar 2007 | - | $20.00 M(0.0%) |
| Dec 2006 | $20.00 M(-88.9%) | $20.00 M(-66.5%) |
| Sep 2006 | - | $59.65 M(-66.9%) |
| Jun 2006 | - | $180.09 M(-0.0%) |
| Mar 2006 | - | $180.10 M(0.0%) |
| Dec 2005 | $180.10 M(-46.2%) | $180.10 M(-38.9%) |
| Sep 2005 | - | $294.55 M(-12.1%) |
| Jun 2005 | - | $335.00 M(0.0%) |
| Mar 2005 | - | $335.00 M(0.0%) |
| Dec 2004 | $335.00 M(+0.5%) | $335.00 M(+6.3%) |
| Sep 2004 | - | $315.00 M(-0.9%) |
| Jun 2004 | - | $317.93 M(+0.9%) |
| Mar 2004 | - | $315.00 M(-5.5%) |
| Dec 2003 | $333.46 M(+2.3%) | $333.46 M(-2.1%) |
| Sep 2003 | - | $340.50 M(+1.0%) |
| Jun 2003 | - | $337.29 M(+2.7%) |
| Mar 2003 | - | $328.52 M(+0.8%) |
| Dec 2002 | $325.94 M(+0.9%) | $325.94 M(+1.4%) |
| Sep 2002 | - | $321.31 M(-0.1%) |
| Jun 2002 | - | $321.73 M(-0.2%) |
| Mar 2002 | - | $322.33 M(-0.2%) |
| Dec 2001 | $323.03 M(-9.6%) | $323.03 M(-8.8%) |
| Sep 2001 | - | $354.19 M(+2.2%) |
| Jun 2001 | - | $346.63 M(-0.1%) |
| Mar 2001 | - | $346.97 M(-2.9%) |
| Dec 2000 | $357.27 M(+7512.8%) | $357.27 M(+2.6%) |
| Sep 2000 | - | $348.12 M(+94.9%) |
| Jun 2000 | - | $178.62 M(-0.3%) |
| Mar 2000 | - | $179.16 M(+3717.5%) |
| Dec 1999 | $4.69 M(-33.0%) | $4.69 M(-11.5%) |
| Sep 1999 | - | $5.30 M(-8.6%) |
| Jun 1999 | - | $5.80 M(-9.4%) |
| Mar 1999 | - | $6.40 M(-8.6%) |
| Dec 1998 | $7.00 M(+18.6%) | $7.00 M(-7.9%) |
| Sep 1998 | - | $7.60 M(+10.1%) |
| Jun 1998 | - | $6.90 M(+11.3%) |
| Mar 1998 | - | $6.20 M(+5.1%) |
| Dec 1997 | $5.90 M(+5.4%) | $5.90 M(+7.3%) |
| Sep 1997 | - | $5.50 M(+1.9%) |
| Jun 1997 | - | $5.40 M(+1.9%) |
| Mar 1997 | - | $5.30 M(-5.4%) |
| Dec 1996 | $5.60 M(+14.3%) | $5.60 M(+27.3%) |
| Sep 1996 | - | $4.40 M(-4.3%) |
| Jun 1996 | - | $4.60 M(+4.5%) |
| Mar 1996 | - | $4.40 M(-10.2%) |
| Dec 1995 | $4.90 M(+4.3%) | $4.90 M(0.0%) |
| Sep 1995 | - | $4.90 M(-3.9%) |
| Jun 1995 | - | $5.10 M(+4.1%) |
| Mar 1995 | - | $4.90 M(+4.3%) |
| Dec 1994 | $4.70 M(+11.9%) | $4.70 M(0.0%) |
| Sep 1994 | - | $4.70 M(+6.8%) |
| Jun 1994 | - | $4.40 M(+12.8%) |
| Mar 1994 | - | $3.90 M(-7.1%) |
| Dec 1993 | $4.20 M(+27.3%) | $4.20 M(+5.0%) |
| Sep 1993 | - | $4.00 M(+2.6%) |
| Jun 1993 | - | $3.90 M(+14.7%) |
| Mar 1993 | - | $3.40 M(+3.0%) |
| Dec 1992 | $3.30 M(+57.1%) | $3.30 M(0.0%) |
| Sep 1992 | - | $3.30 M(+13.8%) |
| Jun 1992 | - | $2.90 M(+26.1%) |
| Mar 1992 | - | $2.30 M(+9.5%) |
| Dec 1991 | $2.10 M(-12.5%) | $2.10 M(-12.5%) |
| Sep 1991 | - | $2.40 M(-4.0%) |
| Jun 1991 | - | $2.50 M(+4.2%) |
| Dec 1990 | $2.40 M | $2.40 M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual long term debt?
- What is the all time high annual long term debt for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual long term debt year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly long term debt?
- What is the all time high quarterly long term debt for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly long term debt year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual long term debt?
The current annual long term debt of VRTX is $724.70 M
What is the all time high annual long term debt for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual long term debt is $889.50 M
What is Vertex Pharmaceuticals Incorporated annual long term debt year-on-year change?
Over the past year, VRTX annual long term debt has changed by -$85.60 M (-10.56%)
What is Vertex Pharmaceuticals Incorporated quarterly long term debt?
The current quarterly long term debt of VRTX is $1.70 B
What is the all time high quarterly long term debt for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly long term debt is $1.70 B
What is Vertex Pharmaceuticals Incorporated quarterly long term debt year-on-year change?
Over the past year, VRTX quarterly long term debt has changed by +$981.60 M (+136.09%)